Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 28, 2020 - The FDA approved Sun Pharmaceutical’s Bynfezia (octreotide acetate) pen.
Download PDF
Return to publications
